Wire Stories
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA� in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma
BOSTON & SHANGHAI & LAUSANNE, Switzerland–(BUSINESS WIRE)–Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT),...